A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
The purpose of this study is to evaluate the efficacy of gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan- uveitis.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
Belo Horizonte, Minas Gerais, Brazil
Tüebingen, Germany
Petoch Tikvah, Israel
Gangnam-gu, SEL, South Korea
Jongno-gu, SEL, South Korea
Secho-gu, SEL, South Korea
Seodaemun-gu, SEL, South Korea
Songpa-g, SEL, South Korea
Taïpeï City, Taiwan